In-vivo whole bladder response to anticholinergic and musculotropic agents in spinal cord injured rats

Journal of Spinal Cord Medicine

Volumn 20, Issue 1, 1997, Pages 31-35

  Shenot, Patrick J ^a   Chancellor, Michael B ^b,e   Rivas, David A ^a   Watanabe, Toyohiko ^a   Kumon, Hiromi ^c   Figueroa, T Ernesto ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^e NONE   (United States)

Author keywords

Incontinence; Neurogenic bladder; Oxybutynin chloride; Spinal cord injury; Urodynamics

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; FLAVOXATE; MANDELIC ACID DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPANTHELINE BROMIDE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; MALE; NEUROGENIC BLADDER; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; URODYNAMICS;

ANIMALS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVOXATE; MALE; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PROPANTHELINE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 0030625961     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.1997.11719389     Document Type: Article

References (24)

1. Wein AJ. Neuromuscular dysfunction of the lower urinary tract. In; Walsh PC, Retick AB, Stamey TA, Vaughan ED Jr, eds. Cambell's urology. 6th ed. Philadelphia, PA; Saunders, 1992: 573-642.
2. Moisey CU, Stephenson TP, Brender CB. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Br J Urol 1980;52:472-5.
3. Salzman SK, Dabney KW, Mendez AA, et al. The somatosensory evoked potential predicts neurologic deficits and serotonergic pathochemistry after spinal distraction injury in experimental scoliosis. J Neurotrauma 1988;5:173-86.
4. Tarlov I. Spinal cord compression studies. III. Time limits for recovery after gradual compression in dogs. Arch Neurol Psych 1954;71:588.
5. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977;47:577-81.
6. Wein AJ, Van Arsdalen KN, Levin RM. Pharmacologic therapy. In; Krane RJ, Siroky MB, eds. Clinical neuro-urology. Boston, MA; Little Brown, 1991:523-58.
7. Blaivas JG, Labib KB, Michalik SJ, Zayed AA. Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications. J Urol 1980;124:259-62.
8. Andersson KE. Current concepts in the treatment of disorders of micturition. Drugs 1988;35:477-94.
9. th ed. New York, NY; Pergamon Press, 1990:150-65.
10. Cardozo LD, Cooper D, Versi E. Oxybutynin chloride in the management of idiopathic detrusor instability. Neurourol Urodynam 1987;6:256-7.
11. Thuroff J, Bunke B, Ebner A, et al. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: Oxybutynin versus propantheline versus placebo. J Urol 1991;145:813-7.
12. Moore KH, Hay DM, Imrie AE, Watson A, Goldstein M. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol 1990;66:479-85.
13. Hehir M, Fitzpatrick FM. Oxybutynin and the prevention of urinary incontinence in spina bifida. Eur Urol 1985;11:254-6.
14. Holmes DM, Monty FJ, Stanton SL. Oxybutynin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial. Br J Obstet Gynaecol 1989;96:607-12.
15. Gajewski JB, Awad JA. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. J Urol 1986;135:966-8.
16. Batista JE, Caffaratti J, Garat JM. Epistaxis as a side effect of Oxybutynin in children: report of two cases. Neurourol Urodynam 1994;13:85-6.
17. Delaere KP, Michiels HG, Debruyne FM, Moonen WA. Flavoxate hydrochloride in the treatment of detrusor instability. Urol Int 1977;32:377-81.
18. Jonas U, Petri E, Kissal J. The effect of flavoxate on hyperactive detrusor muscle. Eur Urol 1979;5:106-9.
19. Briggs RS, Castleden CM, Asher MJ. The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly. J Urol 1980;123:665-6.
20. Chapple CR, Parkhouse H, Gardener C, Milroy EJ. Doubleblind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability. Br J Urol 1990;66:491-4.
21. Rivas, DA, Chancellor MB, Huang B, Salzman SK. Autonomic dysreflexia in a rat model spinal cord injury and the effect of pharmacologic agents. Neurourol Urodynam 1995;14:141-52.
22. Wang ZE, Gopalakurup SK, Levin RM, Chacko S. Expression of smooth muscle myosin isoforms in urinary bladder smooth muscle during hypertrophy and regression. Lab Invest 1995;73:244-51.
23. de Groat WC. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Paraplegia 1995;33:493-505.
24. Somogyi GT, Tanowitz M, de Groat WC. M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J Physiol 1994;480:81-9.